Anant Raj Limited (NSE: ANANTRAJ)
India
· Delayed Price · Currency is INR | Market Cap | 231.46B |
| Revenue (ttm) | 18.20B |
| Net Income (ttm) | 3.52B |
| Shares Out | n/a |
| EPS (ttm) | 10.30 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Jul 12, 2024 |
| Volume | 834,743 |
| Open | 679.65 |
| Previous Close | 672.50 |
| Day's Range | 666.80 - 681.95 |
| 52-Week Range | 249.00 - 796.25 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2024 |
About Anant Raj
Anant Raj Limited is primarily engaged in the real estate and infrastructure development business in India. It develops and constructs residential townships, group housings, commercial developments, information and technology parks, malls, office complexes, affordable housings, data centres, hospitality, and serviced apartments. The company was formerly known as Anant Raj Industries Limited and changed its name to Anant Raj Limited in October 2012. Anant Raj Limited was founded in 1969 and is headquartered in New Delhi, India. [Read more]
Financial Performance
In 2023, Anant Raj's revenue was 14.83 billion, an increase of 55.00% compared to the previous year's 9.57 billion. Earnings were 2.66 billion, an increase of 75.97%.
Financial StatementsNews
B.L. Kashyap and Sons secures new order worth ₹250 crore for residential project
B.L. Kashyap and Sons Limited, a prominent player in civil engineering and construction, has recently secured a new order valued at approximately ₹250 crore. The project, awarded by Anant Raj Limited,...
Morning Gainers Today: Rainbow Children’s, Cipla, L&T, Anant Raj, and Kaynes Tech among top gainers as stocks rally
Here are some of the top gainers on the NSE this morning: Rainbow Children’s Medicare Ltd (RAINBOW) Price: ₹1,622.30 Change: +₹142.10 (+9.60%) Cipla Ltd (CIPLA) Price: ₹1,535.30 Change: +₹117.05 (+8.2...
Stock market update: Q2 FY25 results today for Sumitomo Chemical, Pfizer, Poly Medicure, Firstsource, Anant Raj, CAMS, Kalpatru, Railtel and more
A variety of companies across the chemical, pharmaceutical, healthcare, technology, and infrastructure sectors are set to release their Q2 FY25 earnings results today. Investors and analysts will focu...